New Evidence Update on Crohn's disease from NICE
An Evidence Update on Crohn's disease has been published by NICE.
NICE Evidence Updates help to reduce the need for individuals, managers and commissioners to search for new evidence and keep health and social care professionals up-to-date with new research. While Evidence Updates do not replace current accredited guidance and do not provide formal recommendations, they do highlight new evidence that health and social care professionals may wish to consider alongside current guidance.
The new Evidence Update focuses on a summary of selected new evidence relevant to NICE clinical guideline 152 'Crohn's disease: management in adults, children and young people' (2012).
Free-to-view webinar 'Constipation in children and young people: implementing the NICE quality standard'
MGP, the publisher of Guidelines and Guidelines in Practice has produced free-to-view webinars for healthcare professionals to help them keep up to date with best practice and maintain their guideline-related learning.
Constipation in children and young people: implementing the NICE quality standard
The webinar will be presented by Dr Hasan Chowhan and Lynne Watson on Wednesday 22nd October, 2 - 3pm and will:
- Discuss the NICE quality standard on constipation in children and young people
- Provide a GP perspective on implementing best practice
Dr Falk Pharma UK/Core Awards 2015
The Dr Falk Pharma UK/Core Awards 2015
The Dr Falk/Core awards recognise those who bring new knowledge and insight to the field of gastroenterology and hepatology. For those committed to furthering research or patient care, this year's awards are an opportunity to achieve national recognition as well as the financial support for career progression.
This year's prizes include:
- A £1,000 essay prize for medical students on BSc or MRes courses
- Four £1,500 bursaries for medical students taking full time science degrees
- Two £2,500 bursaries to support research for F1/F2 doctors
- A £1,000 award for primary and secondary care nurses for initiatives which have advanced patient care.
The application deadline is 5pm on Monday 16th March 2015. Applications received after this time will not be considered.
Please visit Core's website to download an application form.
Cancer Genetics in Clinical Practice
A Guide to Cancer Genetics in Clinical Practice
BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.
This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.
View Flyer / Purchasing Details [ 38 Kb ]
Publication date: June 2009
BSG Guidance on Coeliac Disease 2010
The Management of Adults with Coeliac Disease
There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.
An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).
The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).
In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.
- BSG Response to White Paper: 'Healthy Lives, Healthy People'
- Chicago Classification Criteria of Esophageal Motility Disorders (EPT)
- Consensus statements for management of Barrett's dysplasia and early-stage oesophageal adenocarcinoma
- Exercise Linked to More Diverse Gut Microbiota, But Diet Likely Plays a Role
Page 4 of 19